A randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression.
This historical record does not confirm current site availability.
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- United Kingdom
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
This is historical registry information. What is the current study status and protocol?
Things to check before joining
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- South London and Maudsley NHS Foundation Trust [...] 1. South London and Maudsley NHS Foundation Trust 2. King's College London
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United Kingdom
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2016-001637-27
- Official title
Show the full official title
A randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression.
Recruitment & locations
United Kingdom
Registry details
Original registry record (opens in a new tab)- United Kingdom — GB - no longer in EU/EEA
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is South London and Maudsley NHS Foundation Trust [...] 1. South London and Maudsley NHS Foundation Trust 2. King's College London, a university.
Is this study still recruiting?
The registry lists this study as not recruiting.
